Private equity has built deep playbooks for cost reduction, procurement transformation, and operational efficiency. Most operating partners can recite the standard levers in their sleep: headcount rationalization, supplier renegotiation, shared services, working capital optimization. These are well-understood, well-resourced, and well-executed.
Pricing is none of those things. Despite being the single highest-leverage driver of profit improvement, pricing rarely receives the same analytical depth, executive attention, or organizational investment as cost-side initiatives. The result is a persistent gap between the value available and the value captured — a gap that compounds through hold periods and exit multiples.
The economics explain why this matters. Across a range of studies, pricing consistently shows the highest profit sensitivity of any operational lever. McKinsey’s analysis of midsize US companies found that the profit impact of a 1% pricing improvement was roughly 1.5 times greater than an equivalent reduction in variable costs, and more than five times the impact of a fixed-cost reduction of the same magnitude. The reason is structural: unlike cost savings — which often require trade-offs in capability or quality — or volume growth — which carries variable cost — pricing gains hit the bottom line with minimal offset. For PE-owned businesses, that EBITDA impact then compounds through exit multiples, making pricing one of the few levers that simultaneously improves operating performance and valuation.
And yet, according to McKinsey’s survey of over 100 PE professionals, the average firm’s value-creation plan places substantially less emphasis on pricing than on other drivers. The pattern holds even among firms that acknowledge pricing’s impact — a disconnect between belief and behavior that has persisted for years.
Why the Gap Persists: Fear, Timing, and Organizational Readiness
Three factors explain why PE firms consistently underinvest in pricing despite understanding its economics.
The first is risk perception. When McKinsey surveyed PE leaders about barriers to pricing action, the top concerns were competitive response and customer defection. Deal partners worry that price moves will trigger retaliation or erode relationships built over years. This fear is understandable but, in practice, disproportionate to the actual risk. Pricing improvements targeted at segments with differentiated value, low price transparency, or limited competitive alternatives rarely trigger the defection scenarios that executives imagine. The key qualifier is “targeted” — blanket increases do carry real risk, which is precisely why surgical, data-driven pricing matters.
The second is timing. Most PE firms treat pricing as a Year 2 or Year 3 initiative — something to address after the cost-side work is done and the management team is settled. But pricing value is time-sensitive in ways that cost reduction is not. Every quarter of delayed action is margin not captured, EBITDA not built, and exit value not created. The firms that embed pricing into their first 100 days capture gains that fund the rest of the transformation; the firms that wait until mid-hold often find that the window for easy wins has narrowed.
The third is organizational capability. Bain’s 2020 Global Private Equity Report found that 85% of management teams believe their pricing decisions need improvement, but only 15% have effective tools and dashboards for setting and monitoring prices. Even more striking, just 13% reported having effective frontline incentives for pricing integrity. This means that even when a PE firm commits to pricing, the portfolio company often lacks the infrastructure to execute. Pricing becomes a strategy exercise that produces a deck but not margin improvement.
Where Pricing Creates Value — and Where Most Firms Miss It
The highest-impact pricing work in PE isn’t about raising list prices uniformly. It’s about finding and closing the gaps between the value delivered and the price realized — gaps that exist in virtually every portfolio company but are invisible without the right analysis.
These gaps show up in several places. Off-invoice discounts and rebates that have crept up over time without governance. Inconsistent pricing across geographies or channels for identical products. Customer segments receiving the same price despite materially different willingness to pay. Products priced based on cost-plus formulas that ignore competitive positioning and perceived value. Surcharges for expedited shipping, small orders, or extended payment terms that are contractually available but never enforced.
The common thread: these are execution problems, not strategy problems. The pricing architecture may be sound on paper, but value leaks at the transaction level through discounting behavior, exception approvals, and frontline negotiation. This is why governance, incentive alignment, and sales enablement matter as much as the pricing analysis itself.
For distribution businesses in particular, the leverage is dramatic. McKinsey’s analysis of 130 publicly traded distributors estimated that the EBITDA sensitivity to a 1% price improvement was roughly 22% — reflecting the thin-margin, high-volume economics of the sector. Distributors that undertake comprehensive pricing transformations can see earnings expansion of up to 50% with minimal volume impact, according to the same research. Those numbers explain why pricing is increasingly a thesis-level value driver in distribution-focused PE deals.
Starting Earlier: Why Diligence Is the Right Moment
The conventional view is that pricing work starts after close. The more sophisticated view — increasingly adopted by top-quartile firms — is that it starts in diligence.
EY-Parthenon’s survey of global PE funds found that the managers with the least exposure to unforeseen deal risk incorporated pricing analysis into diligence 55% of the time, compared to just 35% for the most risk-exposed managers. A majority of funds surveyed reported including pricing optimization findings in their base-case underwriting. The implication is clear: the most disciplined buyers are already treating pricing as a diligence workstream, not a post-close discovery.
Effective pricing diligence doesn’t require full data-room access. A deal team can assess competitive price positioning through outside-in benchmarking, evaluate historical price elasticity from publicly available or management-reported data, gauge customer price-value perception through expert networks and targeted surveys, and estimate pricing capability maturity based on management interviews and organizational structure. The goal isn’t to build a complete pricing strategy during diligence — it’s to size the opportunity with enough confidence to inform the bid and shape the Day 1 plan.
McKinsey documented a case that illustrates this well. A PE firm was evaluating a fast-growing healthcare target but had no access to transaction-level financials. Rather than deferring pricing analysis to post-close, the deal team built an outside-in picture of the opportunity — combining competitive benchmarking with payer and patient research conducted through expert networks and targeted surveys. The resulting segment-by-segment view of pricing headroom gave the investment committee enough confidence to incorporate a portion of the upside into their bid, allowing them to win a competitive auction while preserving most of the value for the hold period.
The First 100 Days: Building Momentum That Self-Funds
The post-close window is where pricing value is either captured or lost. Firms that build pricing into their first 100 days establish the analytical baseline, quantify quick wins, and — critically — demonstrate early results that build organizational buy-in for deeper changes.
The rapid diagnostic phase typically covers three areas: a geography-by-geography, channel-by-channel, segment-by-segment view of current pricing and margin performance; identification of the largest gaps between value delivered and price realized; and prioritization of quick wins that can generate cash within one to two quarters. EY-Parthenon’s research suggests that well-executed portfolio company pricing strategies can meaningfully improve return on sales — impact that, for lower-margin businesses, translates to a substantial lift in earnings.
But diagnosis without execution infrastructure is just a strategy deck. The first 100 days must also establish the governance that makes pricing discipline stick: approval thresholds for discounting, standardized concession menus with give-get requirements, incentives aligned to margin realization rather than volume alone, and dashboards that track realized price versus list. Without these mechanisms, the announced increase leaks away at the transaction level — the same execution failure that plagues pricing programs at non-PE-owned companies.
Exit Preparation: Proving the Capability, Not Just the Results
The exit is where pricing work either compounds or evaporates. Buyers don’t just want to see that margins improved — they want to understand whether the improvement is sustainable, repeatable, and extensible under new ownership.
This means the exit story needs to include both a track record and a forward roadmap. What pricing initiatives were executed, what results did they produce, and what identified opportunities remain? The more specific and auditable this narrative, the more confidently buyers can underwrite continued pricing improvement into their own models.
McKinsey described one industrial distribution business that began exit preparation six months before launching its sale process. The management team audited a two-year pricing program, identified areas of progress and shortfall, added new margin-optimization initiatives for specific product categories, and revised their forward pricing roadmap. Buyers responded aggressively because they were evaluating a demonstrated capability — a team that had executed pricing improvements and could articulate exactly where additional value remained. That’s a fundamentally different buyer conversation than presenting untested pricing upside in a management presentation.
From Lever to Discipline: What Sustained Pricing Excellence Looks Like
The firms that capture the full potential of pricing aren’t running one-time pricing projects. They’re building organizational capabilities that persist through the hold period and transfer value to the next owner.
In practice, this means a pricing function with clear ownership — whether a dedicated team, a center of excellence embedded in the commercial organization, or a pricing workstream within the value-creation office. It means analytics infrastructure that enables real-time visibility into pricing performance, discount leakage, and margin by customer, product, and channel. It means regular cadence reviews where pricing gets the same executive attention as operational KPIs. And it means sales enablement — scripts, objection-handling guides, and negotiation tools — that gives the frontline confidence to defend value rather than default to discounting.
The common thread across industries and deal types: pricing improvement is primarily an execution and organizational problem, not an analytics problem. The data science matters, but it’s table stakes. The firms that win are the ones that start early, build the governance to sustain gains, and treat pricing with the same operational rigor they bring to procurement, supply chain, or manufacturing excellence.
Key Takeaway
Pricing is the highest-impact, most underutilized value-creation lever in private equity. The profit sensitivity to pricing exceeds that of cost reduction by a significant margin, and because pricing gains hit the bottom line with minimal offset, they compound through exit multiples. Yet most firms either ignore pricing, start too late, or lack the organizational infrastructure to realize the gains their analysis identifies. The firms capturing outsized value are the ones embedding pricing into diligence, building execution capability in the first 100 days, and treating pricing as a sustained discipline rather than a one-time exercise.
If you’re a deal partner or portfolio company executive looking to capture the full value of pricing, I’d welcome a conversation about what we’ve seen work — and what hasn’t. Reach out directly to explore how Quantide Growth Partners can help you build pricing into your diligence process and first 100 days.
———
## References
1. McKinsey & Company, “Pricing: The Next Frontier of Value Creation in Private Equity,” 2019 — source for profit sensitivity analysis of midsize US companies (pricing vs. variable cost vs. fixed cost impact), margin expansion ranges for PE portfolio companies, survey of 100+ PE professionals on barriers to pricing investment, healthcare diligence case study, and industrial distributor exit preparation case study.
2. EY-Parthenon, PE Pricing Report, 2025 — source for survey findings on pricing diligence frequency among PE funds (55% vs. 35% by risk exposure), and majority of global PE funds including pricing optimization in base-case underwriting.
3. EY-Parthenon research — source for portfolio company pricing strategies meaningfully improving return on sales.
4. Bain & Company, “Global Private Equity Report,” 2020 — source for survey findings that 85% of management teams believe pricing decisions need improvement, 15% have effective pricing tools/dashboards, and 13% have effective frontline pricing incentives.
5. McKinsey & Company, “Pricing: Distributors’ Most Powerful Value-Creation Lever,” 2019 — source for finding that a 1% price increase yields approximately 22% EBITDA improvement for distributors, and that end-to-end pricing transformations can expand earnings by up to 50%.
